|
Innocell Corp - Company Profile Snapshot
| Company Profile: |
Innocell Corp |
| Ticker: |
031390 |
| Exchanges: |
SEO |
| 2008 Sales: |
3,186,800,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Wholesalers |
| Country: |
KOREA (SOUTH) |
| Employees: |
53 |
Business Description
Innocell Corp. The Company's principal actvity is developing immune cell treatment drugs and the storage of immune cells. The Company's offerings include immune cell therapy, which is an anti cancer therapy using immune cells from the patient's own body; life cell bank, which collects and freezes anti cancer immune cells before receiving therapy that can weaken the immune system; cord blood bank, which stores hematopoietic stem cells and stem cells that are separated from core blood at an ultra low temperature, and extreme drug resistance (EDR) assay service, which is a test for patient's resistance to anti cancer drugs. The Company is also involved in the distribution of information technology (IT) products.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
